These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 15007909

  • 1. [Suppressive effect of angiotensin converting enzyme inhibitor (ACEI) on the progression of renal insufficiency: a propensity score analysis].
    Hirabayashi A, Ogawa T, Urashima M, Sone M, Nihei H.
    Nihon Jinzo Gakkai Shi; 2004 Jan; 46(1):35-42. PubMed ID: 15007909
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
    Heinze G, Mitterbauer C, Regele H, Kramar R, Winkelmayer WC, Curhan GC, Oberbauer R.
    J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
    [Abstract] [Full Text] [Related]

  • 3. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
    Bazzi C, Rizza V, Paparella M, Casellato D, Napodano P, Olivieri G, D'Amico G.
    J Nephrol; 2009 Mar; 22(3):387-96. PubMed ID: 19557716
    [Abstract] [Full Text] [Related]

  • 4. The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis.
    Jafar TH, Schmid CH, Stark PC, Toto R, Remuzzi G, Ruggenenti P, Marcantoni C, Becker G, Shahinfar S, De Jong PE, De Zeeuw D, Kamper AL, Strangaard S, Levey AS.
    Nephrol Dial Transplant; 2003 Oct; 18(10):2047-53. PubMed ID: 13679479
    [Abstract] [Full Text] [Related]

  • 5. ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy.
    Stigant CE, Cohen J, Vivera M, Zaltzman JS.
    Am J Kidney Dis; 2000 Jan; 35(1):58-63. PubMed ID: 10620545
    [Abstract] [Full Text] [Related]

  • 6. Strict blood-pressure control and progression of renal failure in children.
    ESCAPE Trial Group, Wühl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Afonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen AM, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, Möller K, Wigger M, Peruzzi L, Mehls O, Schaefer F.
    N Engl J Med; 2009 Oct 22; 361(17):1639-50. PubMed ID: 19846849
    [Abstract] [Full Text] [Related]

  • 7. [Clinical effects of trandolapril in chronic glomerulonephritis patients with renal insufficiency].
    Yoshida A, Takeda A, Fukuda M, Toda S, Morozumi K.
    Nihon Jinzo Gakkai Shi; 2000 May 22; 42(4):333-7. PubMed ID: 10897592
    [Abstract] [Full Text] [Related]

  • 8. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
    Giri S, Mahajan SK, Sen R, Sharma A.
    J Assoc Physicians India; 2002 Oct 22; 50():1245-9. PubMed ID: 12568207
    [Abstract] [Full Text] [Related]

  • 9. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.
    Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, Ponticelli C, Ritz E, Zucchelli P.
    N Engl J Med; 1996 Apr 11; 334(15):939-45. PubMed ID: 8596594
    [Abstract] [Full Text] [Related]

  • 10. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 11; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 11. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.
    Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Ghadanfar M, Weissbach N, Xiang Z, Armbrecht J, Pfeffer MA.
    Nephrol Dial Transplant; 2009 May 11; 24(5):1663-71. PubMed ID: 19145003
    [Abstract] [Full Text] [Related]

  • 12. [Can angiotensin-converting enzyme inhibitor be used in chronic kidney disease patients with serum creatinine level greater than 266 micromol/L?].
    Zhang GH, Hou FF, Zhang X, Liu QF.
    Zhonghua Nei Ke Za Zhi; 2005 Aug 11; 44(8):592-6. PubMed ID: 16194413
    [Abstract] [Full Text] [Related]

  • 13. Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease.
    Kent DM, Jafar TH, Hayward RA, Tighiouart H, Landa M, de Jong P, de Zeeuw D, Remuzzi G, Kamper AL, Levey AS.
    J Am Soc Nephrol; 2007 Jun 11; 18(6):1959-65. PubMed ID: 17475813
    [Abstract] [Full Text] [Related]

  • 14. No clear evidence of ACEi efficacy on the progression of chronic kidney disease in children with hypodysplastic nephropathy--report from the ItalKid Project database.
    Ardissino G, Viganò S, Testa S, Daccò V, Paglialonga F, Leoni A, Belingheri M, Avolio L, Ciofani A, Claris-Appiani A, Cusi D, Edefonti A, Ammenti A, Cecconi M, Fede C, Ghio L, La Manna A, Maringhini S, Papalia T, Pela I, Pisanello L, Ratsch IM, ItalKid Project.
    Nephrol Dial Transplant; 2007 Sep 11; 22(9):2525-30. PubMed ID: 17526542
    [Abstract] [Full Text] [Related]

  • 15. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
    Esnault VL, Ekhlas A, Nguyen JM, Moranne O.
    Nephrol Dial Transplant; 2010 Jul 11; 25(7):2218-24. PubMed ID: 20106824
    [Abstract] [Full Text] [Related]

  • 16. Cross-sectional study of heart failure therapy with angiotensin converting enzyme inhibitors and digoxin.
    Mahmood SA, Hussein GM, Hamza EA.
    Saudi Med J; 2004 Aug 11; 25(8):1060-5. PubMed ID: 15322598
    [Abstract] [Full Text] [Related]

  • 17. Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting.
    Miceli A, Capoun R, Fino C, Narayan P, Bryan AJ, Angelini GD, Caputo M.
    J Am Coll Cardiol; 2009 Nov 03; 54(19):1778-84. PubMed ID: 19682819
    [Abstract] [Full Text] [Related]

  • 18. Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency.
    Hou FF, Xie D, Zhang X, Chen PY, Zhang WR, Liang M, Guo ZJ, Jiang JP.
    J Am Soc Nephrol; 2007 Jun 03; 18(6):1889-98. PubMed ID: 17494885
    [Abstract] [Full Text] [Related]

  • 19. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
    Pölzl G, Gouya G, Hügel H, Frick M, Ulmer H, Pachinger O.
    Wien Klin Wochenschr; 2002 Oct 31; 114(19-20):833-9. PubMed ID: 12503474
    [Abstract] [Full Text] [Related]

  • 20. Discontinuation of angiotensin-converting enzyme inhibitors: a cohort study.
    Wong MC, Lau RK, Jiang JY, Griffiths SM.
    J Clin Pharm Ther; 2012 Jun 31; 37(3):335-41. PubMed ID: 22023456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.